U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07572747) titled 'Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countries' on April 28.
Brief Summary: Determine the long-term efficacy of clopidogrel compared with aspirin in reducing heart or brain attacks in patients with stable heart disease
Study Start Date: April 01, 2027
Study Type: INTERVENTIONAL
Condition:
Chronic Coronary Syndrome
Intervention:
DRUG: Clopidgrel 75 mg daily
Clopidogrel
DRUG: Aspirin
Aspirin
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Khalid F Alhabib
Information provided by (Responsible Party): Khalid F Alhabib, Saudi Heart Association
Published by HT Digital Content Services with per...